openPR Logo

Press Releases from Juvenile Myelomonocytic Leukemia Therapeutics- Pharma Proff (1 total)

Juvenile Myelomonocytic Leukemia Therapeutics- Pipeline Analysis 2018

Juvenile myelomonocytic leukemia is a rare disease that occurs mostly in the children who are under four years of age. The abnormal growth of the monocytes results in the accumulation of monocytes in the bone marrow. Download the sample report @ https://www.pharmaproff.com/request-sample/1116 This leads to improper functioning of the bone marrow. The actual cause of juvenile myelomonocytic leukemia is still unknown; however, mutation in the RAS gene is observed in patients